MDL | MFCD00077376 |
---|---|
Molecular Weight | 318.13 |
Molecular Formula | C14H10Cl2NNaO2 |
SMILES | O=C(O[Na])C1=CC=CC=C1NC2=C(Cl)C=CC(C)=C2Cl |
Meclofenamic acid (Meclofenamate) sodium is a nonsteroidal anti-inflammatory drug (NSAID) approved for use in arthritis (osteo and rheumatoid), analgesia (mild to moderate pain), dysmenorrhea, and heavy menstrual blood loss (menorrhagia). Meclofenamic acid sodium is a non-selective gap-junction blocker and a highly selective inhibitor of fat mass and obesity-associated (FTO) enzyme inhibitor [1] [2] [3] .
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT02930005 | The University of Texas Health Science Center, Houston |
Psychotic Disorders|Schizophrenia|Schizoaffective Disorder|Bipolar Disorder
|
August 7, 2015 | Phase 2 |
NCT02429570 | Memorial Sloan Kettering Cancer Center |
Recurrent Brain Metastases|Progressive Brain Metastases
|
April 22, 2015 | Not Applicable |
Solid
Room temperature in continental US; may vary elsewhere.
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
DMSO : 125 mg/mL ( 392.92 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 3.1434 mL | 15.7168 mL | 31.4337 mL |
5 mM | 0.6287 mL | 3.1434 mL | 6.2867 mL |
10 mM | 0.3143 mL | 1.5717 mL | 3.1434 mL |